Magnesium sulphate for tetanus

First, they studied tetanus-a disease frequently forgotten, but certainly not gone,3 with an estimated global incidence of a million cases a year.4 Second, they did a randomised trial of a therapeutic intervention for tetanus, which is rare-there have been only nine such trials for tetanus in the pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2006-10, Vol.368 (9545), p.1398-1399
1. Verfasser: Simini, Bruno
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:First, they studied tetanus-a disease frequently forgotten, but certainly not gone,3 with an estimated global incidence of a million cases a year.4 Second, they did a randomised trial of a therapeutic intervention for tetanus, which is rare-there have been only nine such trials for tetanus in the past 30 years.5 Third, they assessed an inexpensive, easily available drug-magnesium sulphate-also a unique feature because too often randomised trials are industry-sponsored research of expensive agents that might be unavailable in some health-care systems. Magnesium sulphate is safe, and reduces the need to use other drugs to control tetanic muscle spasms and autonomic dysfunction: fewer courses of the benzodiazepine midazolam (given for severe spasms), of the curare-like drug pipecuronium, and of the calcium-channel blocker verapamil were given to patients allocated continuous infusions of magnesium sulphate than those allocated placebo.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(06)69445-2